In particular, the authors focused on the BraTS 2020 and 2021 datasets to train a model for tumor segmentation, while the dataset presented in the Brain Tumor AI Challenge (https://www.kaggle.com/competitions/rsna-miccai-brain-tumor-radiogenomic-classification) [17] is used for MGMT promoter methylation detection. This evidence concerns the gene MGMT and brain neoplasm.